Home

Hydroxyprogesterone acetate

Hydroxyprogesterone acetate

Specifications

302-23-8CAS Number
206-119-6EC Number
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetateIUPAC Name
C23H32O4Chemical Formula
372.5 g/molMolecular Weight
302-23-8; HYDROXYPROGESTERONE ACETATE; 17alpha-Acetoxyprogesterone; Prodox acetate; Acetoxyprogesterone; Pregn-4-ene-3,20-dione, 17-(acetyloxy)-; 17-Hydroxypregn-4-ene-3,20-dione acetate; 17.alpha.-Acetoxyprogesterone; L124O66YSI; 17-Acetoxyprogesterone; DTXSID90894096; U 5533; U-5533; EINECS 206-119-6; NSC 12191; NSC-12191; 17-Hydroxyprogesterone 17alpha-acetate; 17-(Acetyloxy)pregn-4-ene-3,20-dione; 17-AP; 17alpha-Acetoxypregnen-4-en-3,20-dion; 3,20-Dioxo-4-pregnen-17alpha-yl acetate; HYDROXYPROGESTERONE ACETATE [WHO-DD]; HYDROXYPROGESTERONE ACETATE [WHO-IP]; U5533; EC 206-119-6; 3,20-Dioxopregn-4-en-17-yl acetate; Pregn-4-ene-3,20-dione, 17-hydroxy-, acetate; MEGESTROL ACETATE IMPURITY K [EP IMPURITY]; 17-Hydroxyprogesterone acetate; MEDROXYPROGESTERONE ACETATE IMPURITY H [WHO-IP]; 3,20-DIOXOPREGN-4-EN-17-YL ACETATE [WHO-IP]; 17.ALPHA.-HYDROXY-4-PREGNENE-3,20-DIONE ACETATE; MEDROXYPROGESTERONE ACETATE IMPURITY H [EP IMPURITY]; MEGESTROL ACETATE IMPURITY K (EP IMPURITY); MEDROXYPROGESTERONE ACETATE IMPURITY H (EP IMPURITY); Medroxyprogesterone Acetate Impurity H; RefChem:789542; DTXCID701324135; 17ALPHA-HYDROXY-4-PREGNENE-3,20-DIONE ACETATE; 206-119-6; 17-(Acetyloxy)progesterone; 17308-02-0; 17|A-Hydroxyprogesterone acetate; 17alpha-Hydroxyprogesterone acetate; MFCD00021156; [(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate; 17alpha-acetoxy-progesterone; 17-alpha-Hydroxyprogesterone 17-acetate; (8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate; Prokan; 17a-hydroxyprogesterone acetate; 3,20-Dioxopregn-4-en-17-yl Acetate (Hydroxyprogesterone Acetate); Megestrol Acetate EP Impurity K; 17alpha-acetoxypregn-4-ene-3,20-dione; 17-a-Acetoxyprogesterone; hydroxyprogesterone-acetate; UNII-L124O66YSI; SCHEMBL260023; orb3139111; CHEMBL3273984; MSK2206; CHEBI:197158; 17a-Hydroxyprogesterone 17-acetate; HY-N0347; Chlormadinone acetate impurity G CRS; MSK2206-100A; 17a-Acetoxy-4-pregnene-3,20-dione; AKOS015955630; 17alpha-Hydroxyprogesterone 17-acetate; AC-6840; FA39590; 17alpha-Acetoxy-4-pregnene-3,20-dione; [(8S,9R,10S,13R,14R,17S)-17-Acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate; DA-54186; DS-11426; PD062692; SY074793; 17-Hydroxypregn-4-ene-3,20-dioneacetate; 4-Pregnen-17?-ol-3,20-dione ace tate; 17.alpha.-Acetoxy-4-pregnene-3,20-dione; CS-0015252; H1527; NS00084998; 4-Pregnen-17.alpha.-ol-3,20-dione acetate; D97614; 17alpha-Hydroxypregn-4-ene-3,20-diene Acetate; 17alpha-Hydroxyprogesterone 17-acetate, >=98%; F818596; 17.alpha.-Hydroxy-4-pregnene-3,20-dione 17-acetate; BRD-K92902018-001-01-9; Q19597551; Hydroxyprogesterone acetate Solution in Acetonitrile, 100ug/mL; Megestrol Acetate EP Impurity K; Medroxyprogesterone Acetate EP Impurity H; Chlormadinone acetate impurity G, European Pharmacopoeia (EP) Reference StandardSynonyms